Basit öğe kaydını göster

dc.contributor.authorTopkan, Erkan
dc.contributor.authorOzdemir, Yurday
dc.contributor.authorKucuk, Ahmet
dc.contributor.authorBesen, Ali Ayberk
dc.contributor.authorMertsoylu, Huseyin
dc.contributor.authorSezer, Ahmet
dc.contributor.authorSelek, Ugur
dc.date.accessioned2020-12-15T11:48:47Z
dc.date.available2020-12-15T11:48:47Z
dc.date.issued2019
dc.identifier.issn1932-6203en_US
dc.identifier.urihttps://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0218627/1/pone.0218627.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20201215%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20201215T114320Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=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
dc.identifier.urihttp://hdl.handle.net/11727/5049
dc.description.abstractBackground To investigate the detrimental effects of prolonged overall radiotherapy duration (ORTD) on survival outcomes of stage IIIB/C NSCLC patients treated with concurrent chemoradiotherapy (C-CRT) Methods The study cohort consisted of 956 patients who underwent C-CRT for stage IIIB/C NSCLC. Primary endpoint was the association between the ORTD and overall survival (OS) with locoregional progression-free survival (LRPFS) and PFS comprising the secondary endpoints. Receiver operating characteristic (ROC) curve analysis was utilized for accessibility of the cut-off that interacts with survival outcomes. Multivariate Cox model was utilized to identify the independent associates of survival outcomes. Results The ROC curve analysis exhibited significance at 49 days of ORTD cut-off that dichotomized patients into ORTD<50 versus ORTD >= 50 days groups for OS [area under the curve (AUC): 82.8%; sensitivity: 81.1%; specificity: 74.8%], LRPFS (AUC: 91.9%; sensitivity: 90.6%; specificity: 76.3%), and PFS (AUC: 76.1%; sensitivity: 72.4%; specificity: 68.2%), respectively. Accordingly, ORTD >= 50 days group had significantly shorter median OS (P<0.001), LRPFS (P<0.001), and PFS (P<0.001); and 10-year actuarial locoregional control (P<0.001) and distant metastases-free (P<0.011) rates than the ORTD<50 days group. The ORTD retained its significant association with survival outcomes at multivariate analyses independent of the other favorable covariates (p<0.001, for OS, LRPFS, and PFS): Stage IIIB disease (versus IIIC), lymph node bulk <2 cm (versus >= 2 cm), and 2-3 chemotherapy cycles (versus 1). The higher sensitivity for LRPFS (90.6%) than PFS (72.4%) on ROC curve analysis suggested the prolonged ORTD-induced decrements in locoregional control rates as the major cause of the poor survival outcomes. Conclusions Longer ORTD beyond >= 50 days was associated with significantly poorer OS, LRPFS and PFS outcomes, where reduced locoregional control rates appeared to be the main causative.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1371/journal.pone.0218627en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectTREATMENT TIMEen_US
dc.subjectRADIATION-THERAPYen_US
dc.subjectLOCAL-CONTROLen_US
dc.subjectPHASE-IIIen_US
dc.subjectSEQUENTIAL CHEMORADIOTHERAPYen_US
dc.subjectRETROSPECTIVE ANALYSISen_US
dc.subjectTHORACIC RADIOTHERAPYen_US
dc.subjectCHEMOTHERAPY WORTHen_US
dc.subjectADVANCED HEADen_US
dc.subjectCANCERen_US
dc.titleSignificance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patientsen_US
dc.typearticleen_US
dc.relation.journalPLOS ONEen_US
dc.identifier.volume14en_US
dc.identifier.issue7en_US
dc.identifier.wos000484974100008en_US
dc.identifier.scopus2-s2.0-85069855309en_US
dc.contributor.pubmedID31329602en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster